Fig. 4From: Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseasesExample of one case showing radiological worsening in the 6 months preceding antifibrotic initiation and no significant changes after 6 months since their initiation. Figure also shows the fully automatic lung parenchyma segmentation as obtained by in-house YACTA softwareBack to article page